Cargando…
Introduction of the Rapid Deployment Aortic Valve System Use in Elderly Patients With Endocarditis
INTRODUCTION: The rapid-deployment valve system (RDVS) was introduced to facility minimally invasive aortic valve replacement. In this study we evaluate the potential benefits of RDVS in elderly high-risk patients with endocarditis of the aortic valve. MATERIALS AND METHODS: Since the introduction o...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980357/ https://www.ncbi.nlm.nih.gov/pubmed/35391848 http://dx.doi.org/10.3389/fcvm.2022.774189 |
_version_ | 1784681373396631552 |
---|---|
author | Öner, Alper Hemmer, Christoph Alozie, Anthony Löser, Benjamin Dohmen, Pascal M. |
author_facet | Öner, Alper Hemmer, Christoph Alozie, Anthony Löser, Benjamin Dohmen, Pascal M. |
author_sort | Öner, Alper |
collection | PubMed |
description | INTRODUCTION: The rapid-deployment valve system (RDVS) was introduced to facility minimally invasive aortic valve replacement. In this study we evaluate the potential benefits of RDVS in elderly high-risk patients with endocarditis of the aortic valve. MATERIALS AND METHODS: Since the introduction of RDVS in our institution in December 2017 through October 2021, EDWARDS INTUITY rapid-deployment prosthesis (Model 8300A, Edwards Lifesciences, Irvine, CA, USA) has been implanted in a total of 115 patients for different indications by a single surgeon. Out of one-hundred and fifteen cases of RDVS implantation, seven patients with a median age of 77 yrs. (range 62–84yrs.), suffered from active infective endocarditis of the aortic valve. The median EuroSCORE II of these highly selected patient cohort was 77% (range 19–80%). Patient data were evaluated perioperatively including intra-operative data as well as in-hospital morbidity/mortality and follow-up after discharge from hospital. RESULTS: Three patients underwent previous cardiac surgery. Concomitant procedures were performed in six patients including, ascending aorta replacement (n = 3), mitral valve repair (n = 1), pulmonary valve replacement (n = 1), bypass surgery (n = 1), left atrial appendix resection (n = 1) and anterior mitral valve repair (n = 1). Median aortic cross-clamp and cardiopulmonary bypass time was 56 min (range 29–122 min) and 81 min (range 45–162 min.), respectively. Post-operative complications in these elderly high-risk patients were atrial fibrillation (n = 3) and re-exploration for pericardial effusion (n = 1). One pacemaker implantation was required on postoperative day 6 due to sick sinus syndrome. There was one in-hospital death (14%) and one during follow-up (14%). CONCLUSION: Rapid-deployment aortic valve system seems to be a viable option with acceptable morbidity and mortality in elderly high-risk patients with active infective endocarditis of the aortic valve. |
format | Online Article Text |
id | pubmed-8980357 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89803572022-04-06 Introduction of the Rapid Deployment Aortic Valve System Use in Elderly Patients With Endocarditis Öner, Alper Hemmer, Christoph Alozie, Anthony Löser, Benjamin Dohmen, Pascal M. Front Cardiovasc Med Cardiovascular Medicine INTRODUCTION: The rapid-deployment valve system (RDVS) was introduced to facility minimally invasive aortic valve replacement. In this study we evaluate the potential benefits of RDVS in elderly high-risk patients with endocarditis of the aortic valve. MATERIALS AND METHODS: Since the introduction of RDVS in our institution in December 2017 through October 2021, EDWARDS INTUITY rapid-deployment prosthesis (Model 8300A, Edwards Lifesciences, Irvine, CA, USA) has been implanted in a total of 115 patients for different indications by a single surgeon. Out of one-hundred and fifteen cases of RDVS implantation, seven patients with a median age of 77 yrs. (range 62–84yrs.), suffered from active infective endocarditis of the aortic valve. The median EuroSCORE II of these highly selected patient cohort was 77% (range 19–80%). Patient data were evaluated perioperatively including intra-operative data as well as in-hospital morbidity/mortality and follow-up after discharge from hospital. RESULTS: Three patients underwent previous cardiac surgery. Concomitant procedures were performed in six patients including, ascending aorta replacement (n = 3), mitral valve repair (n = 1), pulmonary valve replacement (n = 1), bypass surgery (n = 1), left atrial appendix resection (n = 1) and anterior mitral valve repair (n = 1). Median aortic cross-clamp and cardiopulmonary bypass time was 56 min (range 29–122 min) and 81 min (range 45–162 min.), respectively. Post-operative complications in these elderly high-risk patients were atrial fibrillation (n = 3) and re-exploration for pericardial effusion (n = 1). One pacemaker implantation was required on postoperative day 6 due to sick sinus syndrome. There was one in-hospital death (14%) and one during follow-up (14%). CONCLUSION: Rapid-deployment aortic valve system seems to be a viable option with acceptable morbidity and mortality in elderly high-risk patients with active infective endocarditis of the aortic valve. Frontiers Media S.A. 2022-03-22 /pmc/articles/PMC8980357/ /pubmed/35391848 http://dx.doi.org/10.3389/fcvm.2022.774189 Text en Copyright © 2022 Öner, Hemmer, Alozie, Löser and Dohmen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Öner, Alper Hemmer, Christoph Alozie, Anthony Löser, Benjamin Dohmen, Pascal M. Introduction of the Rapid Deployment Aortic Valve System Use in Elderly Patients With Endocarditis |
title | Introduction of the Rapid Deployment Aortic Valve System Use in Elderly Patients With Endocarditis |
title_full | Introduction of the Rapid Deployment Aortic Valve System Use in Elderly Patients With Endocarditis |
title_fullStr | Introduction of the Rapid Deployment Aortic Valve System Use in Elderly Patients With Endocarditis |
title_full_unstemmed | Introduction of the Rapid Deployment Aortic Valve System Use in Elderly Patients With Endocarditis |
title_short | Introduction of the Rapid Deployment Aortic Valve System Use in Elderly Patients With Endocarditis |
title_sort | introduction of the rapid deployment aortic valve system use in elderly patients with endocarditis |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980357/ https://www.ncbi.nlm.nih.gov/pubmed/35391848 http://dx.doi.org/10.3389/fcvm.2022.774189 |
work_keys_str_mv | AT oneralper introductionoftherapiddeploymentaorticvalvesystemuseinelderlypatientswithendocarditis AT hemmerchristoph introductionoftherapiddeploymentaorticvalvesystemuseinelderlypatientswithendocarditis AT alozieanthony introductionoftherapiddeploymentaorticvalvesystemuseinelderlypatientswithendocarditis AT loserbenjamin introductionoftherapiddeploymentaorticvalvesystemuseinelderlypatientswithendocarditis AT dohmenpascalm introductionoftherapiddeploymentaorticvalvesystemuseinelderlypatientswithendocarditis |